Literature DB >> 15934996

Onset of expression of the components of the Kell blood group complex.

Jeffrey J Pu1, Colvin M Redman, Jan W M Visser, Soohee Lee.   

Abstract

BACKGROUND: Kell and XK, two distinct red blood cell membrane proteins, are linked by a disulfide bond and form the Kell blood group complex. Kell surface antigens are expressed early during erythropoiesis but the onset of expression of XK which carries the Kx antigen is unknown. STUDY DESIGN AND METHODS: To determine whether Kell and XK are synchronously expressed, sorted human hematopoietic progenitor cells and mouse progenitor cells of defined lineage were studied. To determine the onset of expression, human marrow and cord blood cells were sorted into three subpopulations, representing stem, multipotent, and erythroid progenitor cells, and the expression of Kell and XK was determined by reverse transcription-polymerase chain reaction (RT-PCR) and fluorescence-activated cell sorting (FACS) analysis. Mouse Kell and XK transcripts were determined by cDNA blotting of progenitor cells of defined lineage.
RESULTS: By RT-PCR, human peripheral blood progenitor cells had weak expression of Kell and XK transcripts but FACS analysis did not detect surface antigens. Kell and XK transcripts are expressed in multipotent progenitor cells and these cells express Kell surface antigens. The expression of Kx antigen in progenitor cells was not determined owing to nonspecific reactions with the antibody. By cDNA blotting, mouse Kell expression was detected in bipotential megakaryocytes-erythroid cells and in colony-forming units-erythroid (CFU-E) and burst-forming units-erythroid (BFU-E), whereas XK was only detected in CFU-E and BFU-E.
CONCLUSION: Both Kell and XK transcripts occur early during erythropoiesis; however, expression may not be coincident because, in mice, Kell transcripts, but not XK, occur in bipotential megakaryocytes-erythroid progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934996     DOI: 10.1111/j.1537-2995.2005.04289.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells.

Authors:  Nicole H Smith; Kate L Henry; Chantel M Cadwell; Ashley Bennett; Jeanne E Hendrickson; Tom Frame; James C Zimring
Journal:  Transfusion       Date:  2012-04-12       Impact factor: 3.157

2.  Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens.

Authors:  M Hönig; W A Flegel; K Schwarz; J F Freihorst; U Baumann; A Seltsam; K-M Debatin; A S Schulz; W Friedrich
Journal:  Bone Marrow Transplant       Date:  2009-06-08       Impact factor: 5.483

3.  Bioinformatics Identification of Candidate Biomarkers in Endomyocardial Biopsy and Peripheral Blood for Cardiac Allograft Rejection.

Authors:  Kang Luo; Lin Li; Mingyao Meng; Yan Chen; Zongliu Hou
Journal:  Ann Transplant       Date:  2022-03-29       Impact factor: 1.530

4.  Chronic granulomatous disease and McLeod syndrome: Stem cell transplant and transfusion support in a 2-year-old patient-a case report.

Authors:  Louise Helander; Chris McKinney; Kathleen Kelly; Samantha Mack; Mary Sanders; Janice Gurley; Larry J Dumont; Kyle Annen
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.